Ghost Tree Capital’s Mirati Therapeutics MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-60,000
| Closed | -$2.61M | – | 87 |
|
|
2023
Q3 | $2.61M | Sell |
60,000
-140,000
| -70% | -$5M | 0.86% | 41 |
|
|
2023
Q2 | $7.23M | Buy |
200,000
+60,000
| +43% | +$2.47M | 2.39% | 16 |
|
|
2023
Q1 | $5.2M | Sell |
140,000
-60,000
| -30% | -$2.7M | 1.54% | 27 |
|
|
2022
Q4 | $9.06M | Buy |
200,000
+25,000
| +14% | +$1.62M | 3.87% | 11 |
|
|
2022
Q3 | $12.2M | Buy |
175,000
+65,000
| +59% | +$4.81M | 3.43% | 10 |
|
|
2022
Q2 | $7.38M | Buy |
110,000
+90,000
| +450% | +$5.72M | 3.85% | 9 |
|
|
2022
Q1 | $1.64M | Sell |
20,000
-10,000
| -33% | -$1.02M | 0.36% | 37 |
|
|
2021
Q4 | $4.4M | Sell |
30,000
-30,000
| -50% | -$4.66M | 1.58% | 25 |
|
|
2021
Q3 | $10.6M | Buy |
60,000
+10,000
| +20% | +$1.61M | 3.1% | 10 |
|
|
2021
Q2 | $8.08M | Hold |
50,000
| – | – | 2.22% | 14 |
|
|
2021
Q1 | $8.56M | Hold |
50,000
| – | – | 2.01% | 17 |
|
|
2020
Q4 | $11M | Sell |
50,000
-10,000
| -17% | -$2.16M | 2.45% | 18 |
|
|
2020
Q3 | $10M | Sell |
60,000
-95,000
| -61% | -$13M | 2.88% | 9 |
|
|
2020
Q2 | $17.7M | Buy |
155,000
+40,000
| +35% | +$3.88M | 4.67% | 6 |
|
|
2020
Q1 | $8.84M | Sell |
115,000
-35,000
| -23% | -$3.14M | 2.34% | 15 |
|
|
2019
Q4 | $19.3M | Sell |
150,000
-125,000
| -45% | -$12.1M | 3.68% | 6 |
|
|
2019
Q3 | $21.4M | Sell |
275,000
-60,000
| -18% | -$5.63M | 5.46% | 4 |
|
|
2019
Q2 | $34.5M | Buy |
335,000
+185,000
| +123% | +$14.4M | 7.16% | 5 |
|
|
2019
Q1 | $11M | Sell |
150,000
-250,000
| -63% | -$17M | 2.87% | 13 |
|
|
2018
Q4 | $17M | Sell |
400,000
-35,300
| -8% | -$1.41M | 6.16% | 2 |
|
|
2018
Q3 | $20.5M | Sell |
435,300
-64,700
| -13% | -$3.6M | 4.36% | 4 |
|
|
2018
Q2 | $24.6M | Buy |
500,000
+237,500
| +90% | +$8.97M | 7.25% | 2 |
|
|
2018
Q1 | $8.06M | Sell |
262,500
-337,500
| -56% | -$9.37M | 1.63% | 19 |
|
|
2017
Q4 | $11M | Buy |
+600,000
| New | +$9.31M | 2.57% | 12 |
|
|
2017
Q2 | – | Sell |
-172,184
| Closed | -$895K | – | 79 |
|
|
2017
Q1 | $895K | Hold |
172,184
| – | – | 0.17% | 60 |
|
|
2016
Q4 | $818K | Sell |
172,184
-102,816
| -37% | -$559K | 0.2% | 65 |
|
|
2016
Q3 | $1.82M | Buy |
275,000
+200,000
| +267% | +$1.06M | 0.29% | 69 |
|
|
2016
Q2 | $410K | Sell |
75,000
-175,000
| -70% | -$2.79M | 0.12% | 60 |
|
|
2016
Q1 | $5.35M | Hold |
250,000
| – | – | 3.03% | 13 |
|
|
2015
Q4 | $7.9M | Buy |
+250,000
| New | +$8.83M | 3.23% | 11 |
|
Other funds holding MRTX
BBA
B
Ghost Tree Capital's MRTX Position: Q4 2023 in Review
Ghost Tree Capital sold out of Mirati Therapeutics (MRTX) in Q4 2023, closing a stake of 60,000 shares — an estimated $2.61M sold.
Ghost Tree Capital first reported a position in MRTX in Q4 2015 and held it in 30 quarters. The position peaked at $34.5M in Q2 2019. 217 funds tracked by Wall St. Rank hold MRTX as of Q4 2023.
- Ghost Tree Capital reported no remaining Mirati Therapeutics position as of Q4 2023 after selling out during the quarter.
- Ghost Tree Capital sold 60,000 Mirati Therapeutics shares in Q4 2023, an estimated $2.61M.
- Ghost Tree Capital first reported a position in Mirati Therapeutics in Q4 2015 and held it in 30 quarters.
- Ghost Tree Capital's Mirati Therapeutics position peaked at $34.5M in Q2 2019.
- 217 funds tracked by Wall St. Rank held Mirati Therapeutics as of Q4 2023.
Based on Ghost Tree Capital's 13F filing for Q4 2023, filed 14 Feb 2024.